您的位置: 首页 > 农业专利 > 详情页

Beta-amyloid oligomers for use in the treatment, alleviation or prevention of Alzheimer's disease
专利权人:
PRANA BIOTECHNOLOGY LIMITED;THE GENERAL HOSPITAL CORPORATION
发明人:
BUSH, ASHLEY,CHERNY, ROBERT,TANZI, RUDOLPH, EMILE
申请号:
DK01947033
公开号:
DK1296705T3
申请日:
2001.06.28
申请国别(地区):
DK
年份:
2012
代理人:
摘要:
This invention relates to methods and compositions for the treatment or alleviation of Alzheimer's disease and of other conditions related to abnormal protein aggregation. In particular, the invention relates to methods and compositions for the immunotherapy of Alzheimer's disease, Parkinson's disease, and cataract. In one aspect the invention provides a method of prophylaxis, treatment or alleviation of a condition characterized by pathological aggregation and accumulation of a specific protein associated with an immunizing-effective dose of one or more tyrosine cross-linked compounds, and optionally also comprising copper ions complexed to the compound. Alternatively passive immunization against a tyrosine cross-linked compound may be used. Prophylactic or therapeutic compositions and diagnostic methods are also disclosed and claimed.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充